0 items USD 0.00Search
- Did you mean
- ruxolitinib
Your search for "tofacitinib" gave back 65 results.
The global Tofacitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
The global Generic Tofacitinib market was valued at US$ 936.4 million in 2023 and is anticipated to reach US$ 1342.7 million by 2030, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 2,900.00
Tofacitinib, also known as Xeljanz, is a type of drug known as a Janus kinase (JAK) inhibitor. It works by blocking the action of Janus kinase...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 2,900.00
Highlights The global Tofacitinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of %...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
The global Pharmaceutical Grade Tofacitinib Citrate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
颁补迟补濒辞驳:听
MRRPB5
May 2023
Price: USD 2,900.00
Highlights The global Generic Tofacitinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 2,900.00
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary According to the...
颁补迟补濒辞驳:听
Global 麻豆原创s Direct
May 2018
Price: USD 3,500.00
The global Janus Kinase (JAK) Inhibitors market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
颁补迟补濒辞驳:听
GIR
August 2024
Price: USD 3,480.00
Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Pipeline Review, H2 2018 Summary Tyrosine Protein...
颁补迟补濒辞驳:听
Global 麻豆原创s Direct
November 2018
Price: USD 3,500.00
The global Tyrosine Kinase JAK Inhibitors market size was valued at US$ 29820 million in 2023. With growing demand in downstream market, the Tyrosine...
颁补迟补濒辞驳:听
LPI
January 2024
Price: USD 3,660.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 4,000.00
The global Janus Kinase (JAK) Inhibitors market size was valued at US$ million in 2023. With growing demand in downstream market, the Janus Kinase (...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
The global JAK inhibitor Drug market size was valued at US$ 1077.1 million in 2023. With growing demand in downstream market, the JAK inhibitor Drug...
颁补迟补濒辞驳:听
LPI
September 2024
Price: USD 3,660.00
The global Tyrosine Kinase JAK Inhibitors market size is predicted to grow from US$ 67220 million in 2025 to US$ 845210 million in 2031; it is...
颁补迟补濒辞驳:听
LPI
December 2024
Price: USD 3,660.00
The global JAK Inhibitor Based Cancer Drug market size was valued at US$ 1077.1 million in 2023. With growing demand in downstream market, the JAK...
颁补迟补濒辞驳:听
LPI
September 2024
Price: USD 3,660.00
听
